To The Moon

远程医疗公司Hims & Hers Health Inc.(HIMS.us)于2024年10月30日盘中股价大跌16.06%,引发市场关注。 根据分析师看法,这很可能与该公司减肥药业务所面临的竞争加剧有关。 10月30日,诺和诺德公司的减肥药Wegovy在美国获准上市所有五种剂量强度。这一竞品进入市场或引发了投资者对Hims & Hers Health在减肥药领域业务前景的担忧。 分析机构Leerink Partners指出,尽管GLP-1类似减肥药营收目前在公司总收入中仍占比很小,但HIMS的股价波动可能会受到相关新闻的影响。这种风险可能导致股价经历不必要的大起大落。

Hims & Hers (NYSE:HIMS), the telehealth platform that offers compounded versions of weight loss drugs, dropped more than 10% on Thursday after the FDA confirmed that Eli Lilly's (LLY) GLP-1 tirzepatid

Shares of Hims & Hers Health Inc. plunged nearly 8% in pre-market trading on Wednesday, as investors reacted to concerns over the potential end of a shortage that has allowed the telehealth company to offer affordable versions of popular weight-loss drugs.Hims & Hers has been selling compounded versions of drugs like Wegovy and Ozempic, which are used for weight loss and diabetes treatment, at a fraction of the cost charged by pharmaceutical giants Eli Lilly and Novo Nordisk. The company has be

We recently compiled a list of the 10 Worst AI Stocks to Buy According to Reddit. In this article, we will look at where SoFi Technologies Inc. ranks among the worst AI stocks to buy.In the lead-up to the September rate cut decision, analysts had expressed a variety of opinions regarding the 50 basis-point cut, with some supporting and others opposing it. Some of them suggested that lower interest rates could create opportunities in small and mid-cap stocks, which may benefit from a more favorable borrowing environment.Michael Khouw, OpenInterest.PRO Chief Strategist, discussed that the stock market experienced a broadly lower performance recently, with the NASDAQ Composite suffering the most significant decline, down 0.5%. The S&P 500 also saw a decrease, giving up 24 points to close below 5,700, while the Dow Jones Industrial Average was down by 60 points at the time of reporting. Despite this overall downturn, the utility sector outp